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Synthesis and evaluation of some steroidal oximes as cytotoxic agents:
Structure/activity studies (II)
Jianguo Cui , Lei Fan , Yanmin Huang , Yi Xin , Aimin Zhou
Introduction
The synthesis and isolation of some steroidal oximes with
unusual and interesting structures have been reported recently
[1–7]. These compounds exhibit valuable biological activities such
as cytotoxicity and aromatase inhibitory activity. Interestingly, the
analysis of the chemical structure andbiofunctionshas showed that
the cytotoxicity of these compounds against cancer cells is depen-
dent on the location of the hydroximino group on the steroidal
nucleus. The parental steroids with a hydroximino group located at
adifferentpositiondisplaya remarkabledifference in their cytotox-
icities. In this study, we synthesized a series of hydroximinosteroid
derivatives with a different functional group on the ring A or B and
various side chain types at position 17, and systemically analyzed
the cytotoxicity of these compounds against several types of cancer
cells including Sk-Hep-1 (human liver carcinoma cell line), H-292
(human lung carcinoma cell line), PC-3 (human prostate carcinoma
cell line) and Hey-1B (human ovarian carcinoma cell line) cells. Our
results have revealed that presence of a hydroximino at position 3
and a hydroxy at position 6, or vice versa, with a cholesterol-type
side chain at position 17 resulted in an increase of cytotoxic activity
which is consistentwith our previous report [8]. Furthermore elim-
ination of the 4,5-double bond augmented the cytotoxic activity for
the steroidal oximes.
Results and discussion
Chemistry
To determine the effect of the hydroximino position and the
4,5-double bond on the biological role of a steroidal compound, we
synthesized several analogues of steroidal oximes with a hydrox-
imino group on the A or B ring and the absence of the double bond
at position 4 by using natural steroids.
Synthesis of the analogues of (6E)-hydroximino-3-ol (4)
and (6E)-hydroximino-3-one (5) steroids (Scheme 1)
The steroidal oximes 4 and 5, with a hydroxy group or car-
bonyl group on the A ring and a hydroxymino group on the
B ring, were synthesized in 3 steps according to the sequence
shown in Scheme 1. First, the compound 1a was converted to the
corresponding 4-en-3,6-dione (2a) via oxidation with pyridinium
chlorochromate (PCC) in CH2Cl2. Next, cholest-4-en-3,6-dione (2a)
was converted to 3a by selective reduction using NaBH4 in the
presence of NiCl2 in 72% yield according to the synthetic method
we developed [9]. In the reaction, cholest-3,6-diol (6a) was
obtained as a byproduct in 11% yield. The structure of 3a was
conﬁrmed by comparing IR and 1H NMR spectra with those
analogous compounds analyzed previously. The conﬁguration of
C3–H was justiﬁed by its coupling constant of 10.5Hz. (6E)-
hydroximinocholest-3-ol (4a) was generated by the reaction of 3a
with hydroxylamine hydrochloride in ethanol in the presence of
NaOAc in 96% yield. The structure of 4a was conﬁrmed by analysis
of IR, the proton and carbon NMR chemical shifts at C-3 and C-7.
989
Scheme 1. Reagents: (a) PCC, CH2Cl2 (2a: 84%); (b) NaBH4/CH3OH, NiCl2·6H2O (3a: 72%); (c) NH2OH.HCl, AcONa (4a: 96%); (d) PCC, CH2Cl2 (5a: 71%).
Scheme 2. Reagents: (a) NaBH4/CH3OH, NiCl2·6H2O; (b) Jones’ reagent, acetone (7a: 88%); (c) NaAc·3H2O, 95% C2H5OH, NH2OH.HCl (8a: 90%).
In the IR spectra, the absorptions of 1711 cm−1 for the original car-
bonyl group of 3a, was absent and replaced by a new absorption
at 1650 cm−1 (C =N) for 4a. In the 1H NMR spectrum the reso-
nances showing of H-7 at 3.339ppm (dd, J=14.0, 4.0Hz) and C-6 at
160.1ppm demonstrated a position of 6E-hydroximino in 4a [10].
Finally, oxidationof the3-hydroxyof4a toproduce5awasachieved
under different conditions. Although the oxidation with the Jones’
agent or CrO3 in pyridinewas rapid, a better yieldwas obtained and
work up was simpler than that when PCC in dichloromethane was
used. The IRabsorptionof5aat 1693 cm−1 showed that a3-hydroxy
in 4a had been converted to a 3-carbonyl in 5a.
Synthesis of the analogues of (3E)-hydroximino-6-one
steroids (Scheme 2)
To determine the effect of the location of a hydroximino group
on steroidal nucleus on the cytotoxic activity,we synthesized anew
3-hydroximine analogue 8 with an opposite arrangement of the
two functional groups compared to the compound 5. In the prepa-
ration, the compound 2 was selectively reduced to generate the
crude product 3 and 6, which were then directly oxidized to pro-
duce 3,6-diketone (compound 7). The compound 8 was obtained
by the treatment of 7 with hydroxylamine hydrochloride (1:1.1)
in ethanol in the presence of NaOAc. The structure of compound
Scheme 3.
8 was conﬁrmed by its IR and NMR spectra. In the IR spectra, the
absorption of 1711 cm−1 for an original carbonyl group of com-
pound 7a was disappeared and a new absorption at 1653 cm−1 for
compound 8a indicating the presence of C NOH group. 1H NMR
spectrum of 8a showed a ddd-peak at 3.303ppm corresponding to
C2–H, conﬁrming that 3-carbonyl in 7a had been converted to 3E-
hydroximino in 8a (if there is a 6E-hydroximino in 8a, a dd-peak
would been appeared on C7–H).
Synthesis of the analogues of (3E)-hydroximino-6-ol
steroids (Scheme 3)
To evaluate the effect of different groups on the cytotoxic activ-
ity, we synthesized a new compound 9 with a hydroxy group at
position 6. The compound 9was obtained by a reduction of the car-
bonyl group at position 6 in 8a using NaBH4 as a reductive agent in
51% yield. The structure of compound 9 was determined by a com-
parison of its IR and NMR spectral data with 8a. The chemical shift
of H-6 at 3.874ppm and C-6 at 71.2ppm for 9, and the lack of the
chemical shift of C-6 at 210.3ppm for 8a conﬁrmed that 6-carbonyl
of 8a had been converted to 6-hydroxy. The coupling constant of
2.0Hz and a broad doublet for C6–H revealed the presence of an
equatorial hydrogen atom.
Scheme 4.
990
991
Synthesis of the analogues of (3E,6E)-dihydroximino-
steroids (Scheme 4)
To further evaluate the role of the hydroximino location in the
cytotoxic activity of hydroximinosteroids,we synthesized the com-
pound 10 with two hydroximino groups at positions 3 and 6 on
the steroidal ring. The hydroximino groups were introduced by
oximination of 7a in the presence of superﬂuous hydroxylamine
hydrochloride. In the 13C NMR spectra a singlet at 157.2ppm
(C-3) and a singlet at 157.4ppm (C-6) in 10 indicated that 3,6-
dicarbonyl groups in 7a had been converted to 3,6-dihydroximino
groups. The downﬁeld chemical shift of C2–H at 3.088ppm and
C7–H at 3.180ppm in the 1H NMR spectrum of 10 showed the E-
conﬁguration of two oxime groups due to the deshielding inﬂuence
of the OH in the hydroximino group.
Biological evaluation
To determine the effect of the location of the hydroximino
group(s) and the type of a side chain at position 17 on the biological
functions of steroidal analogues, we determined the cytotoxicity of
these compounds against to a variety of cancer cell types including
Sk-Hep-1 (human liver carcinoma cell line), H-292 (human lung
carcinoma cell line), PC-3 (human prostate carcinoma cell line) and
Hey-1B (human ovarian carcinoma cell line) cells. In this study,
we demonstrated that the biological activity of a steroidal oxime
was signiﬁcantly dependent on the location of the hydroximino
group(s) and the type of a side chain at position 17 on the parental
steroid as we previously reported [8]. The results expressed as IC50
values in nanomoles are summarized in Table 1.
Apparently, increased antineoplastic activity among these ana-
logues was observed along with the order of the side chain at
position17: cholesterol-typesidechain (4a,8a) > stigmasterol-type
side chain (4b, 8b) > sitosterol-type side chain (8c). The presence of
a cholesterol-type side chain appears to be necessary for achiev-
ing a higher cytotoxicity. Interestingly, our results revealed that
position of hydroximino on ring A or B have remarkably distinct
cytotoxicities against cancer cells. Presence of an oxime group at
position 3 on the ring A and a carbonyl group at position 6 on the
ring B (8a) exerted signiﬁcantly higher cytotoxicity than 5awith an
opposite arrangement of the two functional groups.
The analogue 4a with a hydroxyl group at C-3 and an oxime
group at C-6 showed a remarkable increase in their cytotoxic activ-
ity in comparison with 5a with a keto group at C-3, suggesting the
importance of the hydroxyl group in the biological function of a
steroidal oxime. Nevertheless, compound 4a and the analogue 9
with an opposite arrangement of the two functional groups did not
show a distinct difference in its cytotoxic activity. Furthermore,
when the 3-hydroxy in 4a, or the 6-hydroxy in 9, is substituted by
an oxime (compound 10), there was no obvious change in the cyto-
toxic activity (the IC50 values of 4a/10, 9/10 as shown in Table 1).
Interestingly, our results indicated that the double bond
between position 4 and 5 on A ring confers a negative effect to
the cytotoxicity against cancer cells for 3-hydroximino-substituted
compounds. Presence of the 4,5-double bond in the analogues 8a–c
with 3-hydroximino-6-carbonyl resulted in a remarkable decrease
of the cytotoxicity of these compounds (comparing relevant com-
pounds we had reported previously in [8]). Similarly, compounds 9
and 10 with 3-hydroximino showed a slight increase in their cyto-
toxicity against these cancer cells in comparison of the analogues
with the similar structure and a 4,5-double bond [8].
Conclusion
We have prepared a series of hydroximinosteroid derivatives
with different substituted groups on the ring A or B, and various
side chain types at position 17. The cytotoxicity of the synthesized
compounds against Sk-Hep-1 (human liver carcinoma cell line),
H-292 (human lung carcinoma cell line), PC-3 (human prostate
carcinoma cell line) and Hey-1B (human ovarian carcinoma cell
line) cellswas investigated. Our results have demonstrated that the
elimination of the 4,5-double bond enhanced the cytotoxic activ-
ity for the 3,6-substituted steroidal oximes with a 3-hydroximino
and a different 6-substituted functional group, and that the pres-
ence of a hydroxy on the A or B ring augmented the cytotoxic
activity for these compounds. Our ﬁndings provide new evidence
showing the relationship between the chemical structure and bio-
logical function. The information obtained from the studies may
be useful for the design of novel chemotherapeutic drugs for can-
cer.
Experimental
Chemistry
The sterols and NaBH4 were purchased from the Merck Co.
The compounds 2a and b were prepared according to reference
[11]. All chemicals and solvents were analytical grade and the sol-
vents were puriﬁed by general methods before being used. Melting
points were determined on an X4 apparatus and were uncorrected.
Infrared spectra were measured with a Nicolet FT-360 Spectropho-
tometer. The 1H and 13C NMR spectra were recorded in CDCl3 on
a Bruker AV-500 spectrometer at working frequencies 500 and
125MHz, respectively. Chemical shifts are expressed in ppm (ı)
values and coupling constants (J) in Hertz. LREIMS were recorded
on a Thermo-DSQ instrument, while HREIMS were measured on a
Thermo-MAT95XP instrument. Thecell proliferationassaywasper-
formed by a MTS method using 96-well plates in Beckman coulter
LD400 AD/LD analysis spectrometer.
3ˇ-Hydroxycholest-6-one (3a)
NaBH4 (0.035g, 0.92mmol) was added to a solution of 2a
(0.119g, 0.3mmol) and NiCl2·6H2O (0.071g, 0.3mmol) in CH3OH
(15mL) in the interval of 5min at room temperature. After 5min,
the reaction was stopped. The solution was neutralized with 1M
HCl. After evaporationof themajority ofMeOHunder reducedpres-
sure, water of 15mL was added. Then the residue was extracted
with ethyl acetate (15×3mL). The resulting solution was washed
with cold water and saturated brine. After drying over anhydrous
sodium sulfate, the solvent was removed under reduced pressure,
and the resulting crude product was puriﬁed by ﬂash chromatog-
raphy on silica gel using petroleum ether/ethyl acetate (1:4) as the
eluent. The 3a was obtained as a white solid (0.087g, 72%), mp
161–162 ◦C. IR (KBr) : 3378, 2937, 2864, 1711, 1466, 1384, 1262,
1172, 1021, 959, 796 cm−1; 1H NMR (CDCl3, 500MHz) ı: 0.666(3H,
s, 18-CH3), 0.756(3H, s, 19-CH3), 0.871(6H,d, J=6.5, 26and27-CH3),
0.918(3H, d, J=6.5, 21-CH3), 1.955(1H, t, J=13.0, C8–H), 2.044(1H,
brd, J=12.5, C7–H), 2.207(1H, brd, J=12.0, C7–H), 2.318(1H,
dd, J=13.5, 4.0, C5–H), 3.575(1H, tdd, J=10.5, 5.0, 3.5, C3–H);
13C NMR(CDCl3, 125MHz) ı: 210.9(C-6), 70.7(C-3), 56.8(C-5), 56.7
(C-14), 56.2(C-17), 54.0(C-9), 49.6(C-10), 46.7(C-13), 42.9(C-12),
39.5(C-24), 38.0(C-8), 36.7(C-1), 36.1(C-20), 35.7(C-22), 31.6(C-7),
30.7(C-2), 30.1(C-4), 28.1(C-16), 28.0(C-25), 24.0(C-15), 23.8(C-23),
22.8(C-26), 22.6(C-27), 21.6(C-11), 18.7(C-21), 13.2(C-19), 12.0(C-
18).
3-Hydroxy-24-ethylcholest-22-en-6-one (3b)
Compound 3b was prepared similarly according to the proce-
dure of 3a. Yield 73%, mp 172–173 ◦C; IR(KBr) : 3411, 2958, 2864,
1707, 1458, 1380, 1229, 1066, 963 cm−1; 1H NMR(CDCl3, 500MHz)
ı: 0.702(3H, s, 18-CH3), 0.779(3H, s, 19-CH3), 0.812(3H, d, J=6.0,
26 or 27-CH3), 0.821(3H, t, J=7.5, 29-CH3), 0.862(3H, d, J=6.0, 26
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or 27-CH3), 1.041(3H, d, J=6.5, 21-CH3), 2.230(1H, dd, J=12.5, 2.0,
C7–H), 2.239(1H, dd, J=13.5, 4.5, C5–H), 3.622–3.560(1H, m,
C3–H), 5.040(1H, dd, J=15.6, 8.5, C22–H), 5.158(1H, dd, J=15.6,
8.6, C23–H).
(6E)-Hydroximinocholest-3ˇ-ol (4a)
CH3COONa·3H2O (0.027g, 0.20mmol) and NH2OH·HCl (0.021g,
0.30mmol) were added to the solution of 3a (0.080g, 0.20mmol)
in 15mL 95% ethanol. After the solution was heated to 55 ◦C, the
mixture was stirred at the temperature for 3h. Then the reac-
tion was terminated and the majority of solvent was evaporated
under reduced pressure. Distilled water was added into the reac-
tion mixture, and the product was extracted with ethyl acetate
(3×20mL). The combined extracts were washed with saturated
brine, dried, and evaporated under reduced pressure. The residue
was subjected to chromatography using petroleum ether/ethyl
acetate (2:1) as theeluent togive0.078gof4a (96%) as awhite solid,
mp 202–204 ◦C. IR(KBr) : 3379, 2941, 2864, 1650, 1466, 1385,
1249, 1061, 988 cm−1; 1HNMR(CDCl3, 500MHz) ı: 0.676(3H, s, 18-
CH3), 0.778(3H, s, 19-CH3), 0.886(3H, d, J=4.3, 26-CH3 or 27-CH3),
0.888(3H, d, J=4.3, 26-CH3 or 27-CH3), 0.927(3H, d, J=5.3, 21-CH3),
3.339(1H, dd, J=14.0, 4.0, C7–H), 3.624–3.578(1H, m, C3–H),
8.374(1H, s, N–OH); 13C NMR(CDCl3, 125MHz) ı: 160.1(C-6),
71.2(C-3), 56.7(C-14), 56.2(C-17), 49.6(C-9), 46.3(C-13), 42.9(C-10),
42.3(C-5), 39.5(C-12), 39.2(C-24), 38.9(C-22), 38.8(C-4), 36.1(C-1),
35.8(C-2), 35.7(C-20), 31.6(C-8), 30.9(C-7), 28.1(C-16), 28.0(C-25),
24.1(C-15), 23.8(C-23), 22.8(C-26), 22.5(C-27), 21.3(C-11), 18.7(C-
21), 12.6(C-19), 12.1(C-18).
(6E)-Hydroximino-24-ethylcholest-22-en-3ˇ-ol (4b)
Compound 4b was prepared similarly according to the proce-
dure of 4a. Yield 98%, mp 196–198 ◦C. IR(KBr) : 3403, 2954, 2872,
1646, 1462, 1380, 1057, 976 cm−1; 1H NMR(CDCl3, 500MHz) ı:
0.698(3H, s, 18-CH3), 0.783(3H, s, 19-CH3), 0.812(6H, d, J=6.0, 26-
CH3 or 27-CH3), 0.829(3H, t, J=7.5, 29-CH3), 0.862(6H, d, J=6.0,
26-CH3 or 27-CH3), 1.037(3H, d, J=6.5, 21-CH3), 3.338(1H, dd,
J=14.0, 4.5, C7–H), 3.524–3.625(1H, m, C3–H), 5.036(1H, dd,
J=15.0, 8.5, C22–H), 5.161(1H, dd, J=15.0, 8.5, C23–H), 7.737(1H,
brs, N–OH); 13C NMR(CDCl3, 125MHz) ı: 160.1(C-6), 138.1(C-
23), 129.5(C-22), 71.2(C-3), 56.8(C-14), 56.0(C-17), 51.2(C-9),
46.2(C-24), 42.8(C-13), 42.3(C-5), 39.6(C-12), 38.9(C-10), 38.8(C-4),
36.3(C-20), 35.8(C-1), 33.6(C-2), 31.6(C-8), 30.9(C-7), 29.6(C-25),
28.8(C-16), 24.2(C-15), 21.5(C-28), 21.2(C-11), 21.0(C-27), 19.0(C-
26), 18.7(C-21), 16.8(C-19), 12.6(C-29), 12.3(C-18).
(6E)-Hydroximinocholest-3-one (5a)
Pyridinium chlorochromate (PCC) (0.034g)was added to a solu-
tion of4a (0.043g, 0.1mmol) in dried CH2Cl2 (10mL) in one portion
at room temperature. The reaction was completed in 4h. The sus-
pensionwas poured over a silica gel column and elutedwith EtOAc.
The resulting solution was washed with cold water and saturated
brines. After drying over anhydrous sodiumsulfate, the solventwas
removed under reduced pressure, and the resulting crude prod-
uct was puriﬁed by chromatography on silica gel using petroleum
ether (60–90 ◦C)/EtOAc (4: 1) as eluent to give 0.030g (71%) of
5a as white solid, mp 169–170 ◦C. IR (KBr) : 2953, 2865, 1693,
1600, 1486, 1249, 1221, 1117, 942 cm−1; 1H NMR(CDCl3, 500MHz)
ı: 0.708(3H, s, 18-CH3), 0.885(6H, d, J=6.5Hz, 26-CH3 and 27-
CH3), 0.938(3H, d, J=6.0, 21-CH3), 0.976(3H, s, 19-CH3), 2.618(2H,
m, C4–H and C5–H), 3.510(1H, m, C7–H); LREIMS(70eV, m/z):
415(M+), 397(M+–H2O); HREIMS: m/z 415.3447 [M]+ (calcd for
C27H45O2N, 415.3445).
(6E)-Hydroximino-24-ethylcholest-22-en-3-one (5b)
CrO3 (0.200g) was dissolved in a mixture of 6mL pyridine and
20mL CH2Cl2. After stirring for 10min, the solution of 4b (0.050g)
in 5mL CH2Cl2 was added slowly. The mixture was stirred at
room temperature for 3.5h. The reaction mixture was ﬁltered with
CH2Cl2 and ﬁltrate was washed with saturated brines, dried with
anhydrous sodium sulfate, and evaporated under reduced pres-
sure. The residue was subjected to chromatography (petroleum
ether (60–90 ◦C)/EtOAc 3:1) to give 0.038g of 5b (76%) as a
white solid, mp 185–187 ◦C. IR(KBr) : 3391, 2983, 2868, 1703,
1612, 1458, 1397, 1270, 1143, 1025, 976 cm−1; 1H NMR(CDCl3,
500MHz) ı: 0.726(3H, s, 18-CH3), 0.824(3H, d, J=6.5Hz, 26-CH3
or 27-CH3), 0.831(3H, t, J=7.0, 29-CH3), 0.874(3H, d, J=6.5, 26-
CH3 or 27-CH3), 0.982(3H, s, 19-CH3), 1.044(3H, d, J=7.0, 21-CH3),
2.125–2.018(2H, m, C2–H), 2.449–2.331(2H, m, C4–H), 2.595(1H,
dd, J=15.0, 13.5, C5–H), 3.373(1H, dd, J=13.8, 4.5, C7–H),
5.053(1H, dd, J=15.2, 8.6, C22–H), 5.175(1H, dd, J=15.2, 8.6, C23–H),
7.529(1H, brs, N–OH); LREIMS(70eV,m/z): 441(M+), 423(M+–H2O),
398(M+-C3H7); HREIMS: m/z 441.3602 [M] + (calcd for C29H47O2N,
441.3601).
Cholest-3,6-dione (7a)
To the stirred solutionof2a (0.100g, 0.25mmol) andNiCl2·6H2O
(0.060g, 0.25mmol) in CH3OH (15mL) was added NaBH4 (0.030g,
0.79mmol) in one time at room temperature. After 30min, the
reaction was stopped. The solution was neutralized with 1M HCl.
After evaporation of the majority of MeOH under reduced pres-
sure, the residue was extracted with ethyl acetate (15×3mL).
The combined extracts were washed with cold water and sat-
urated brines. After drying over anhydrous sodium sulfate, the
solvent was removed under reduced pressure. The resulting solid
was dissolved in 10mL of acetone. The Jones’ reagent was gradu-
ally added into the solution of acetone at 0–5 ◦C until the orange
of solution was not faded. The reaction mixture was continually
stirred at 0 ◦C for 10min and then neutralized with saturated
NaHCO3 solution. The majority of solvent was evaporated under
reduced pressure and then the product was extracted with ethyl
acetate (3×20mL). The combined extracts were washed with
water and saturated brine, dried with anhydrous sodium sul-
fate, and evaporated under reduced pressure. The residue was
subjected to chromatography (petroleum ether (60–90 ◦C)/EtOAc
6:1) to give 0.088g of 7a (88%) as a white solid, mp 172–173 ◦C.
IR(KBr) : 2962, 2864, 1720, 1711, 1462, 1440, 1384, 1258, 1237,
1127, 1094, 992, 923, 612, 514 cm−1; 1H NMR(CDCl3, 500MHz)
ı: 0.704(3H, s, 18-CH3), 0.873(3H, d, J=2.0, 26 or 27-CH3),
0.886(3H, d, J=2.0, 26 or 27-CH3), 0.933(3H, d, J=6.5, 21-CH3),
0.972(3H, s, 19-CH3), 2.344–2.307(1H, m, C2–H), 2.372–2.347(2H,
m, C7–H), 2.396(1H, dd, J=13.0, 4.5, C7–H), 2.610(1H, brs,
C4–H).
24-Ethylcholest-22-en-3,6-dione (7b)
Compound 7b was prepared similarly according to the pro-
cedure of 7a. Yield 82%, mp 190–192 ◦C. IR(KBr) : 2962, 2864,
1731, 1718, 1682, 1609, 972, 864 cm−1; 1H NMR(CDCl3, 500MHz)
ı: 0.736(3H, s, 18-CH3), 0.821(3H, d, J=6.5, 26-CH3 or 27-CH3),
0.829(3H, t, J=7.5, 29-CH3), 0.870(3H, d, J=6.5, 26-CH3 or 27-CH3),
0.984(3H, s, 19-CH3), 1.052(3H, d, J=6.5, 21-CH3), 2.136–2.058(2H,
m, C2–H), 2.357–2.317(1H,m, C7–H), 2.387–2.357(1H,m, C4–H),
2.405(1H, dd, J=13.0, 4.5, C7–H), 2.644–2.579(2H, m, C4–H and
C5–H), 5.058(1H, dd, J=15.0, 9.0, C22–H), 5.172(1H, dd, J=15.0,
8.5, C23–H).
24-Ethylcholest-3,6-dione (7c)
Compound 7c was prepared similarly according to the pro-
cedure of 7a. Yield 83%, mp 163–164 ◦C. IR(KBr) : 2962, 2868,
1707, 1458, 1421, 1394, 1266, 1237, 1168, 1123, 1090 cm−1;
1H NMR(CDCl3, 500MHz) ı: 0.714 (3H, s, 18-CH3), 0.837(3H, d,
J=6.5, 26-CH3 or 27-CH3), 0.859(3H, d, J=6.5, 26-CH3 or 27-CH3),
0.868(3H, t, J=7.8, 29-CH3), 0.949(3H, d, J=6.5, 21-CH3), 0.978(3H,
993
s, 19-CH3), 2.134–2.077(2H, m, C2–H), 2.364–2.302(1H, m, C7–H),
2.452–2.347(2H,m, C4–HandC7–H), 2.640–2.575(2H,m, C4–H
and C5–H).
(3E)-Hydroximinocholest-6-one (8a)
Compound 7a (0.064g, 0.16mmol) was dissolved in 10mL
95% CH3CH2OH. After the mixture was heated to 60 ◦C,
CH3COONa·3H2O (0.022g, 0.16mmol) and NH2OH·HCl (0.013g,
0.18mmol) were added into the solution in 10min. The mix-
ture was stirred for 1 hour at 60 ◦C. Then the reaction was
terminated and the majority of solvent was evaporated under
reduced pressure. Distilled water was added into the reac-
tion mixture, and the product was extracted with ethyl acetate
(3×20mL). The combined extracts were washed with saturated
brine, dried with anhydrous sodium sulfate, and evaporated
under reduced pressure. The residue was subjected to chro-
matography (petroleum ether (60–90 ◦C)/EtOAc 3:1) to produce
0.060g of 8a (90%), mp 180–181 ◦C. IR(KBr) : 3411, 2949,
2929, 2864, 1719, 1653, 1462, 1397, 1337, 1286, 1237, 1163,
1027, 951, 759 cm−1; 1H NMR(CDCl3, 500MHz) ı: 0.696(3H, s,
18-CH3), 0.870(3H, s, 19-CH3), 0.882(3H, d, J=2.0, 26-CH3 or 27-
CH3), 0.895(3H, d, J=2.0, 26-CH3 or 27-CH3), 0.937(3H, d, J=6.5,
21-CH3), 2.387–2.330(3H, m, C5–H and C7–H), 3.303(1H, ddd,
J=16.0, 4.0, 1.5, C2–H); 13C NMR(CDCl3, 125MHz) ı: 210.3(C-6),
159.4(C-3), 57.9(C-5), 56.7(C-14), 56.2(C-17), 53.7(C-13), 46.7(C-9),
43.0(C-7), 41.9(C-10), 39.5(C-12), 39.4(C-24), 38.1(C-22), 38.0(C-8),
37.0(C-20), 36.1(C-25), 35.7(C-16), 28.0(C-4), 26.9(C-2), 24.0(C-
1), 23.8(C-15), 22.8(C-23), 22.6(C-26), 21.5(C-27), 19.7(C-11),
18.7(C-21), 12.4(C-19), 12.0(C-18); LREIMS(70eV, m/z): 415(M+),
398(M+–OH); HREIMS: m/z 415.3446 [M] + (calcd for C27H45O2N,
415.3445).
(3E)-Hydroximino-24-ethylcholest-22-en-6-one (8b)
Compound 8b was prepared similarly according to the pro-
cedure of 8a. Yield 93%, mp 179–180 ◦C. IR(KBr) : 3223, 2953,
2868, 1707, 1666, 1468, 1425, 1397, 1286, 1237, 1172, 1074,
972, 906, 730 cm−1; 1H NMR(CDCl3, 500MHz) ı: 0.716(3H, s,
18-CH3), 0.819(3H, d, J=6.5, 26-CH3 or 27-CH3), 0.826(3H, t,
J=7.5, 29-CH3), 0.867(3H, d, J=6.5, 26-CH3 or 27-CH3), 0.873(3H,
s, 19-CH3), 1.045(3H, d, J=6.5, 21-CH3), 2.384–2.329(3H, m,
C5–H and C7–H), 3.302(1H, ddd, J=15.3, 3.5, 0.5, C2–H),
5.052(1H, dd, J=15.0, 9.0, C22–H), 5.168(1H, dd, J=15.0, 8.5,
C23–H), 7.912(brs, N–OH); 13C NMR(CDCl3, 125MHz) ı: 210.2(C-
6), 159.5(C-3), 137.9(C-22), 129.7(C-23), 57.9(C-5), 56.8(C-14),
56.0(C-17), 53.7(C-24), 51.7(C-13), 46.8(C-20), 42.9(C-9), 41.9(C-
7), 40.4(C-10), 39.4(C-12), 38.0(C-8), 37.0(C-25), 31.9(C-16),
28.7(C-4), 27.2(C-2), 26.9(C-28), 25.4(C-1), 24.1(C-15), 21.5(C-
11), 21.2(C-21), 21.1(C-26), 19.7(C-27), 19.0(C-19), 12.4(C-18),
12.2(C-29); LREIMS(70eV, m/z): 441(M+), 424(M+–OH), 398(M+-
C3H7); HREIMS: m/z 441.3605 [M] + (calcd for C29H47O2N,
441.3601).
(3E)-Hydroximino-24-ethylcholest-6-one (8c)
Compound 8c was prepared similarly according to the pro-
cedure of 8a. Yield 91%, mp 168–170 ◦C. IR(KBr) : 3362, 2962,
2929, 2864, 2839, 1699, 1645, 1462, 1433, 1380, 1335, 1286, 1237,
1168, 1074, 963, 943, 906, 694 cm−1; 1H NMR(CDCl3, 500MHz) ı:
0.689(3H, s, 18-CH3), 0.829 (3H, d, J=6.5, 26 or 27-CH3), 0.851
(3H, d, J=6.5, 26 or 27-CH3), 0.857(3H, s, 19-CH3), 0.859(3H, t,
J=7.5, 29-CH3), 0.937(3H, d, J=6.5, 21-CH3), 2.380–2.316(3H, m,
C5–H and C7–H), 3.293(1H, ddd, J=15.8, 3.8, 1.5, C2–H), 8.830(1H,
brs N–OH); 13C NMR(CDCl3, 125MHz) ı: 210.2(C-6), 159.3(C-3),
56.7(C-5), 56.7(C-14), 56.1(C-17), 53.8(C-24), 46.8(C-13), 45.9(C-9),
43.0(C-7), 41.9(C-10), 39.5(C-12), 38.1(C-20), 38.1(C-8), 36.1(C-22),
33.9(C-25), 29.2(C-16), 28.1(C-4), 27.2(C-2), 26.2(C-23), 24.0(C-
1), 23.1(C-15), 21.5(C-28), 19.8(C-11), 19.8(C-26), 19.1(C-27),
18.7(C-21), 12.5(C-19), 12.1(C-29), 12.0(C-18); LREIMS(70eV,m/z):
443(M+), 426(M+–OH); HREIMS: m/z 443.3757 [M] + (calcd for
C29H49O2N, 443.3758).
(3E)-Hydroximinocholest-6-ol (9)
To a solution of 8a (0.300g, 0.72mmol) in CH3OH (30mL) was
added NaBH4 (0.055g, 1.45mmol) in the interval of 8min at room
temperature. After 20min, the reaction was stopped. The solution
was neutralized with 1M HCl. After evaporation of the majority of
MeOHunder reduced pressure,water of 15mLwas added. Then the
residue was extracted with ethyl acetate (15×3mL). The resulting
solutionwaswashedwithcoldwaterandsaturatedbrine.Afterdry-
ing over anhydrous sodium sulfate, the solventwas removed under
reduced pressure, and the resulting crude product was puriﬁed
by ﬂash chromatography on silica gel using petroleum ether/ethyl
acetate (3:1) as the eluent. The compound 9 was obtained as a
white solid (0.154g, 51.1%), mp 191–192 ◦C. IR (KBr) : 3387,
2937, 2864, 1662, 1466, 1380, 1045, 951 cm−1; 1H NMR(CDCl3,
500MHz) ı: 0.717(3H, s, 18-CH3), 0.873(3H, d, J=2.0, 26 or 27-
CH3), 0.886(3H, d, J=2.0, 26or27-CH3), 0.925(3H, d, J=6.5, 21-CH3),
1.117(3H, s, 19-CH3), 2.283(1H, dd, J=12.0, 5.0, C4–H), 3.055(1H,
dd, J=15.0, 3.5, C2–H), 3.874(1H, brd, J=2.0, C6–H), 8.111(1H,
brs, NOH); 13C NMR(CDCl3, 125MHz) ı: 161.1(C-3), 71.2(C-6),
56.3(C-14), 56.1(C-17), 54.0(C-9), 47.8(C-5), 42.7(C-13), 39.9(C-10),
39.8(C-7), 39.7(C-12), 39.5(C-24), 36.2(C-22), 36.1(C-20), 35.8(C-8),
30.2(C-16), 28.2(C-25), 28.0(C-4), 27.8(C-2), 24.5(C-1), 24.3(C-
15), 23.9(C-23), 22.8(C-26), 22.6(C-27), 21.0(C-11), 18.7(C-21),
15.0(C-19), 12.1(C-18); LREIMS(70eV,m/z): 417(M+), 400(M+–OH),
399(M+–H2O), 382(M+–H2O+OH)); HREIMS: m/z 417.3600 [M] +
(calcd for C27H47O2N, 417.3601).
(3E,6E)-Dihydroximinocholestane (10)
Compound 7a (0.202g, 0.5mmol) was dissolved in 20mL
of 95% CH3CH2OH. After the mixture was heated to 60 ◦C,
CH3COONa·3H2O (0.272g, 2mmol) and NH2OH·HCl (0.138g,
2mmol) were added. The mixture was stirred for 1h at 60 ◦C.
Then the reaction was terminated and the majority of solvent
was evaporated under reduced pressure. Distilled water was
added into the reaction mixture, and the product was extracted
with ethyl acetate. The combined extracts were washed with
water and saturated brine, dried with anhydrous sodium sul-
fate, and evaporated under reduced pressure. The residue was
puriﬁed by ﬂash chromatography on silica gel using petroleum
ether/ethyl acetate (1:1) as the eluent. The compound 10
was obtained as a white solid (0.369g, 86%), mp 194–195 ◦C.
IR(KBr) : 3293, 3174, 3109, 2949, 2868, 1658, 1466, 1392,
1290, 1209, 1160, 1104, 959, 927, 710 cm−1; 1H NMR (DMSO-
d6, 500MHz) ı: 0.633(3H, s, 18-CH3), 0.754(3H, s, 19-CH3),
0.851(6H, d, J=3.0, 26- and 27-CH3), 0.893(3H, d, J=4.0, 21-CH3),
3.088(1H, brd, J=12.5, C2–H), 3.180(1H, brd, J=13.4, C7–H),
10.122(1H, s, 6-NOH), 10.377(1H, s, 3-NOH); 13C NMR(DMSO-
d6, 125MHz) ı: 157.4(C-6), 157.2(C-3), 56.4(C-14), 56.2(C-17),
53.4(C-9), 50.8(C-5), 42.8(C-10), 39.6(C-13), 39.4(C-24), 39.3(C-
12), 36.5(C-22), 36.1(C-20), 35.6(C-8), 35.5(C-16), 29.4(C-25),
28.8(C-7), 28.2(C-2), 27.9(C-1), 24.2(C-19), 23.7(C-15), 23.1(C-23),
22.9(C-4), 21.4(C-27), 20.0(C-26), 19.0(C-11), 12.3(C-21), 11.8(C-
18); LREIMS(70eV, m/z): 430(M+), 413(M+–OH), 398(M+–NOH2),
396(M+–2OH); HREIMS:m/z 430.3553 [M] + (calcd for C27H46O2N2,
430.3554).
Antiproliferative activity
Materials and methods
Stock solutions of the compounds were prepared in sterile
dimethyl sulfoxide (DMSO) (Sigma) at a concentration of 10mg/mL
and afterwards diluted with complete nutrient medium (RPMI-
994
1640) supplemented with 10% heat inactivated fetal bovine serum
and 0.1 g/L penicillin G+0.1 g/L streptomycin sulfate.
Cell culture
Sk-Hep-1, H-292, PC-3 (ATCC) and Hey-1B (A gift from Dr. Yan
Xu, University of Indiana) cells were cultured in a proper medium
supplemented with 10% fetal bovine serum in a humidiﬁed atmo-
sphere of 5% CO2 at 37 ◦C.
Treatment of cancer cells
Cancer cells (4×104 cells/mL, 200L) were seeded into each
well of a96-wellmicrotiterplate.After incubation for24h, thecom-
pounds with a series of concentrations (range 5–80g/mL) were
added to the cells. An equal amount of DMSO was added to the
cells used as negative controls. All were treated in triplicate.
Determination of cell viability
MT Stetrazolium salt ((3-4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
(CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay,
Cat.# G5421, Promega Corporation) dye reduction assay was used
to determine the cell viability. The assay is dependent on the reduc-
tion of MTS by mitochondrial dehydrogenases of viable cells to an
aqueous, blue, soluble formazan product, which can be measured
spectrophotometrically. The absorbance of the formazan product
at 490nm is in linear proportion to cell numbers. Brieﬂy, after
treatment (see Section 4.2.3) for 72h, the medium was removed
and the cells were incubated with 100L of fresh medium plus
20L ofMTS solution for additional 4h according to the instruction
provided by the manufacturer. The absorbance (A) at 490nm was
measured using a LD400 AD/LD analysis spectrometer (Beckman
coulter). The IC50 value was calculated as the concentration of drug
yielding 50% cell survival.
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